Drugs by condition
Drugs approved for growth hormone deficiency
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
5
Still marketed, NDA or BLA
Drug classes
2
Novel drugs
2
New molecular entities and new biologics
In development
4
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for growth hormone deficiency.
- Skytrofa (Lonapegsomatropin-Tcgd) · Ascendis Pharma Encocrinology Div A/S NovelOrphanAug 25, 2021
- Sogroya (Somapacitan-Beco) · Novo Nordisk INC NovelAug 28, 2020
- Omnitrope (Somatropin) · Sandoz OrphanMay 30, 2006
- Norditropin Flexpro (Somatropin) · Novo Nordisk INC OrphanJun 20, 2000
- Genotropin Preservative Free (Somatropin) · Pharmacia Aug 24, 1995
All approved drugs for growth hormone deficiency, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Recombinant Human Growth Hormone (3)
- Skytrofa Lonapegsomatropin-Tcgd · Ascendis Pharma Encocrinology Div A/S · 2021
- Omnitrope Somatropin · Sandoz · 2006
- Norditropin Flexpro Somatropin · Novo Nordisk INC · 2000
Class not listed in FDA's data (2)
- Sogroya Somapacitan-Beco · Novo Nordisk INC · 2020
- Genotropin Preservative Free Somatropin · Pharmacia · 1995
Drugs in development for growth hormone deficiency
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- LUM-201Phase 36 trials
Lumos Pharma · Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity & Overweight
- InpegsomatropinPhase 34 trials
Xiamen Amoytop Biotech Co., Ltd. · Turner Syndrome, Idiopathic Short Stature, Adult Growth Hormone Deficiency
- GB06Phase 31 trial
Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric
- GenSci134Phase 22 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Pediatric Growth Hormone Deficiency, Idiopathic Short Stature
1 discontinued brand-name drugs whose label still names it
- Macrilen Macimorelin Acetate
More on growth hormone deficiency: recruiting trials · published research
Related in endocrinology and women's health: Hypothyroidism · Osteoporosis · Menopause symptoms · Endometriosis · Uterine fibroids · Birth control · Low testosterone · Acromegaly · Cushing's syndrome
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.